*EMBARGOED All research presented at the 2022 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Sunday, October 23, 2022, at 12:00 pm EDT.

Sarah Glover, DO 

Sarah Glover, DO
Poster A0360 Hospitalization and Surgery Rates in Patients Awaiting Approval of Biologics or Small Molecules for Treating Inflammatory Bowel Disease (IBD)
Sunday, October 23, 2022 | 5:00 PM – 7:00 PM ET | Location: Crown Ballroom

Author Insight from Sarah Glover, DO, University of Mississippi Medical Center

What’s new here and important for clinicians?
Delays in insurance prior authorization approvals impact the health outcomes for patients with IBD. IBD patients may experience inpatient stays or even surgical interventions while waiting for their insurance company to prior authorize a prescribed therapy. This results in the overuse of steroids and creates health disparities in select geographic locations with primitive processes. The tribal knowledge of working with insurers and pharmacy benefit managers needs to be better shared. There are many levels of appeal and peer review available to assist IBD prescribers and their patients.

What do patients need to know?
Seek appropriate medical care early in your disease progression. Have a primary care physician and complete annual health maintenance items.

Read the Abstract

Author Contact
Sarah Glover, DO, University of Mississippi Medical Center
scglover [at] umc.edu

Media Interview Requests
To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi.org or by phone at 301-263-9000.